CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.38
Tradestie Score
52
Market Cap
$149.66M
P/E Ratio
5.8
Revenue Growth
0.0%
Analyst Upside
+93.3%
Top Competitors
235 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.52
|
$262.67M | - | 52 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 53 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$32.87
|
$256.54M | - | 55 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$10.68
|
$240.89M | - | 55 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$11.22
|
$211.22M | - | 47 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$5.53
|
$202.58M | - | 60 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$14.87
|
$199.71M | - | 46 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$25.36
|
$188.81M | 325.8 | 47 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.61
|
$180.53M | - | 53 | Compare |
|
MCRB
Seres Therapeutics, Inc.
|
$5.03
|
$179.47M | - | 44 | Compare |
More CGEN Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2836)
235 stocks in this industry